Product Information
BANOPHEN 25 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0572 per EA under NDC 00904723761. Its NADAC has been published 179 times since Jan 25, 2023.
Strength
25 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904723761
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/14/2022
Pharmacological Classes
Price Statistics
The NADAC for BANOPHEN 25 MG CAPSULE has been published 179 times since Jan 25, 2023, and over the history we have for it it has risen 48.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0572 per EA |
|---|---|
| All-time high | $0.0640 (Feb 11, 2026) |
| All-time low | $0.0360 (Jul 17, 2024) |
| 52-week high | $0.0640 |
| 52-week low | $0.0462 |
| Median price | $0.0425 |
| Average price | $0.0460 |
| Largest weekly change | +12.6% (Oct 18, 2023) |
| Weeks tracked | 179 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BANOPHEN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BANOPHEN 25 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0572 per EA (NDC 00904723761), effective Jun 24, 2026.
How has the price of BANOPHEN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BANOPHEN 25 MG CAPSULE has risen 48.1%. It has been tracked across 179 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for BANOPHEN 25 MG CAPSULE?
Since Jan 25, 2023, the NADAC for BANOPHEN 25 MG CAPSULE has ranged from a low of $0.0360 (Jul 17, 2024) to a high of $0.0640 (Feb 11, 2026), with a median of $0.0425 per EA.
Are there cheaper alternatives to BANOPHEN 25 MG CAPSULE?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DIPHENHYDRAMINE 25 MG TABLET, is $0.0366 per EA — about 36% below BANOPHEN 25 MG CAPSULE.
Who manufactures BANOPHEN 25 MG CAPSULE?
BANOPHEN 25 MG CAPSULE (NDC 00904723761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification